Effects of atorvastatin with different doses on hs-CRP level in patients with acute coronary syndrome
Guangyou Wang
Abstract
Guangyou Wang
Abstract
Objective:To investigate effects of atorvastatin with different doses on levels of blood lipid and serum high sensitive C-reactive protein(hs-CRP) in patients with acute coronary syndrome(ACS).Methods:A total of 128 ACS patients were randomly divided into large dosage of atorvastatin group(40mg/d,n=64) and routine dosage of atorvastatin group(20mg/d,n=64).Serum levels of blood lipid,hs-CRP of the two groups were measured with biochemistry assay within 24h after admission,3d and 7d after therapy.The difference in blood lipid and hs-CRP levels was compared between the two groups.Results:(1)After 7d,levels of total cholesterol(TC)[routine dosage group:(4.4±0.9) mmol/L vs.(5.6±1.2) mmol/L,large dosage group:(4.2±0.9) mmol/L vs.(5.7±1.2) mmol/L]and low density lipoprotein-cholesterol(LDL-C) [routine dosage group:(2.1±0.6) mmol/L vs.(3.3±0.7) mmol/L,large dosage group:(2.3±0.7) mmol/L vs.(3.4±0.8) mmol/L]significantly decreased compared with before treatment(P0.05 all),but there was no significant difference between the two groups for above indexes before and after treatment(P0.05);(2)After 7d,hs-CRP level of large dosage group significantly decreased compared with before treatment [(5.0±1.9)mg/L vs.(17.5±6.4)mg/L],and it was more than that of routine dosage group [(7.1±4.8) mg/L,P0.01 all].Conclusion:Application of large dosage of atorvastatin could better decrease hs-CRP level in patients with acute coronary syndromes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate effects of atorvastatin with different doses on levels of blood lipid and serum high sensitive C-reactive protein(hs-CRP) in patients with acute coronary syndrome(ACS).Methods:A total of 128 ACS patients were randomly divided into large dosage of atorvastatin group(40mg/d,n=64) and routine dosage of atorvastatin group(20mg/d,n=64).Serum levels of blood lipid,hs-CRP of the two groups were measured with biochemistry assay within 24h after admission,3d and 7d after therapy.The difference in blood lipid and hs-CRP levels was compared between the two groups.Results:(1)After 7d,levels of total cholesterol(TC)[routine dosage group:(4.4±0.9) mmol/L vs.(5.6±1.2) mmol/L,large dosage group:(4.2±0.9) mmol/L vs.(5.7±1.2) mmol/L]and low density lipoprotein-cholesterol(LDL-C) [routine dosage group:(2.1±0.6) mmol/L vs.(3.3±0.7) mmol/L,large dosage group:(2.3±0.7) mmol/L vs.(3.4±0.8) mmol/L]significantly decreased compared with before treatment(P0.05 all),but there was no significant difference between the two groups for above indexes before and after treatment(P0.05);(2)After 7d,hs-CRP level of large dosage group significantly decreased compared with before treatment [(5.0±1.9)mg/L vs.(17.5±6.4)mg/L],and it was more than that of routine dosage group [(7.1±4.8) mg/L,P0.01 all].Conclusion:Application of large dosage of atorvastatin could better decrease hs-CRP level in patients with acute coronary syndromes.
Key concepts: Atorvastatin, Medicine, Internal medicine, Acute coronary syndrome, Gastroenterology, Blood lipids, Total cholesterol, C-reactive protein